-
NIH, MSKCC researchers publish AI model for predicting immunotherapy responses
Researchers at Memorial Sloan Kettering Cancer Center and the National Institutes of Health’s National Cancer Institute said their AI approach was able to identify patients more likely to have objective responses to immune checkpoint inhibitors as well as forecast short- and long-term survival among different cancers. (Getty Images)
Artificial Intelligence
Archive
Categorise
Recent Posts
- Citing ‘capacity constraints,’ Novo Nordisk plots global wind-down of human insulin pen production
- NIH, MSKCC researchers publish AI model for predicting immunotherapy responses
- ASCO: Replacing chemotherapy with ADCs? AbbVie rebuilds next-gen assets after Rova-T flop
- Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030
- 8 Biotech Companies in Chicago Cultivating the City’s Life Sciences Scene
